#

Prof. Dr. Gabriele Fischer

Director, Addiction Clinic, Center of Public Health and Department of Psychiatry & Psychotherapy, Medical University Vienna, Austria

#

Prof. Christoph U Correll, MD.

The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA. Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA. Charité – Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.

In this discussion, Professors Christoph Correll and Gabriele Fischer address the complexities of treating patients with cooccurring schizophrenia and substance use disorders. The conversation covers the challenges of managing the comorbidity of these disorders.

Related content

Dopamine in Parkinson’s Disease and Schizophrenia play_circle Video play_circle
Dopamine in Parkinson’s Disease and Schizophrenia

Professors Shen-Yang Lim and Christoph Correll explore dopamine’s role in Parkinson’s disease and schizophrenia, discussing treatment evolution, side effects, and parallels between the disorders. Access more resources at Neurotorium.org.

04.12.2024 Parkinson’s Disease
description Article
The Use of Virtual Reality in the Treatment of Severe Mental Illnesses: The Example of Psychosis

The use of virtual reality in the treatment of severe mental illnesses

06.10.2024 Schizophrenia
Diagnostic Challenges in Bipolar Disorder: Depression, Mania, and Schizophrenia play_circle Video play_circle
Diagnostic Challenges in Bipolar Disorder: Depression, Mania, and Schizophrenia

In this video, Professors Lakshmi Yatham, MD., and Christoph Correll, MD. discuss the challenges of differentiating bipolar disorder.

03.09.2024 Bipolar Disorder